SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.35% | +0.98% | +19.21% | +23.22% | +21.40% |
| Gross Profit Growth | +32.36% | +12.48% | +97.86% | +30.15% | -34.70% |
| EBITDA Growth | +15.91% | +19.76% | +14.57% | +51.97% | +34.13% |
| Operating Income Growth | +16.79% | +19.46% | +17.85% | +67.85% | +37.19% |
| Net Income Growth | +58.90% | +17.57% | +24.34% | +79.53% | +28.67% |
| EPS Growth | +58.09% | +17.16% | +18.46% | +70.06% | +20.47% |
| EPS Diluted Growth | +58.09% | +17.16% | +18.46% | +70.06% | +20.47% |
| Weighted Average Shares Growth | +0.23% | +0.23% | +4.96% | +5.57% | +6.81% |
| Weighted Average Shares Diluted Growth | +0.23% | +0.23% | +4.96% | +5.57% | +6.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -13.97% | +0.00% | +3.77% | +0.00% |
| Inventory Growth | +0.00% | +21.84% | +0.00% | +0.70% | +0.00% |
| Asset Growth | +0.00% | +11.47% | +0.00% | +12.49% | +0.00% |
| Book Value per Share Growth | +17.39% | +18.99% | +13.62% | +22.59% | +0.00% |
| Debt Growth | +0.00% | +10.68% | +0.00% | +13.65% | +0.00% |
| R&D Expense Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | -21.78% | -100.00% | +0.00% | +0.00% |